Postdoctoral Research Assistant in Neurodegeneration
University of Oxford, New Headington, Oxford
Postdoctoral Research Assistant in Neurodegeneration
£7-£39424
University of Oxford, New Headington, Oxford
- Full time
- Temporary
- Onsite working
Posted 2 weeks ago, 9 Jul | Get your application in now before you miss out!
Closing date: Closing date not specified
Job ref: 03fece5bfac34b1aa3c331cd184a2908
Location ref: New Headington, Oxford
Full Job Description
You will be responsible for the culture and preparation of cell lines and human iPSC derived cultures. You will run cellular assays to validate targets and determine target engagement. You will work to deadlines and show good attention to detail. You can expect, within a short space of time, to become proficient in several platforms and able to provide technical advice to students and colleagues within the ODDI, or collaborating academic groups.
It is essential that you hold a relevant PhD/DPhil (or be close to completion) in Neuroscience, Biochemistry, Pharmacology, Cell and Molecular Biology or Immunology. You must have excellent practical expertise in cell culture and in vitro assays and hold previous laboratory experience in molecular biology. You must have the ability to manage your own research with an eye for detail and take responsibility for administrative activities such as management of lab reagent stock, lab book writing.
Centre for Medicines Discovery, NDM Research Building, Old Road Campus, Headington, Oxford, OX3 7FZ
We are seeking to appoint a Postdoctoral Research Assistant in Neurodegeneration to join the Alzheimer's Research UK Oxford Drug Discovery Institute (ODDI) at the Centre for Medicines Discovery.
ODDI is one of three research institutes funded by Alzheimer's Research UK and charged with uncovering novel therapeutic approaches for dementia.
The research at the ODDI is focused on molecular mechanisms underpinning innate immunity and organelle homeostasis, which have been revealed by human genetics studies to be hot-spots that harbour many risk alleles for Alzheimer's and Parkinson's disease.
Our mission is to de-risk novel therapeutic approaches so that they are fit for further discovery investment. Consequently, we work closely with pharma and biotech companies and operate industry-style project teams to deliver our target validation and translational goals.